The clinicopathological significance of CD133 and Sox2 in Astrocytic glioma.
CONCLUSIONS: Astrocytoma with CD133 and Sox2 overexpression had an unfavorable prognosis and poor clinical response to the current therapeutic protocol.
PMID: 30248046 [PubMed - as supplied by publisher]
Source: Cancer Biomarkers - Category: Cancer & Oncology Tags: Cancer Biomark Source Type: research
More News: Astrocytoma | Biology | Brain Tumor | Cancer | Cancer & Oncology | Glioma | Stem Cell Therapy | Stem Cells | Study